Carfilzomib for Treatment of Chronic Graft vs. Host Disease
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2016
At a glance
- Drugs Carfilzomib (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 07 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 29 Dec 2015 Planned initiation date changed from 1 Jul 2015 to 1 Feb 2016, as reported by ClinicalTrials.gov.
- 14 Jul 2015 New trial record